[go: up one dir, main page]

PE12098A1 - Composiciones y metodos para tratar transtornos respiratorios - Google Patents

Composiciones y metodos para tratar transtornos respiratorios

Info

Publication number
PE12098A1
PE12098A1 PE1996000570A PE00057096A PE12098A1 PE 12098 A1 PE12098 A1 PE 12098A1 PE 1996000570 A PE1996000570 A PE 1996000570A PE 00057096 A PE00057096 A PE 00057096A PE 12098 A1 PE12098 A1 PE 12098A1
Authority
PE
Peru
Prior art keywords
compositions
methods
alkyl
formula
respiratory disorders
Prior art date
Application number
PE1996000570A
Other languages
English (en)
Spanish (es)
Inventor
Donald Kay Riker
Ronald Dean Cramer
Sekhar Mitra
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE12098A1 publication Critical patent/PE12098A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE1996000570A 1995-07-28 1996-07-26 Composiciones y metodos para tratar transtornos respiratorios PE12098A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50877595A 1995-07-28 1995-07-28
US61152896A 1996-03-05 1996-03-05

Publications (1)

Publication Number Publication Date
PE12098A1 true PE12098A1 (es) 1998-04-19

Family

ID=27056302

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000570A PE12098A1 (es) 1995-07-28 1996-07-26 Composiciones y metodos para tratar transtornos respiratorios

Country Status (8)

Country Link
EP (1) EP0841947A1 (fr)
JP (1) JPH11510168A (fr)
AR (1) AR003470A1 (fr)
AU (1) AU6599196A (fr)
CA (1) CA2227958A1 (fr)
CO (1) CO4750820A1 (fr)
PE (1) PE12098A1 (fr)
WO (1) WO1997004808A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
US5770618A (en) * 1996-11-13 1998-06-23 Nastech Pharmaceutical Company, Inc. Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
EP1014983A1 (fr) * 1997-09-19 2000-07-05 The Procter & Gamble Company Compositions et procedes de traitement de troubles respiratoires
HRP20031057B1 (hr) 2001-06-28 2013-05-31 Ucb Farchim Sa, Z.I. Planchy Tableta koja sadrži cetirizin i pseudoefedrin
HUP0402299A3 (en) * 2001-09-04 2008-04-28 Boehringer Ingelheim Int Anti-influenza drugs containing ambroxol and bromhexine and process for its preparation
US7863287B2 (en) 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
RU2286770C2 (ru) * 2004-11-22 2006-11-10 Закрытое акционерное общество "Научно-производственное объединение "Антивирал" (ЗАО "НПО "Антивирал") Антигриппозное средство
JP5598108B2 (ja) * 2009-07-09 2014-10-01 ライオン株式会社 内服用固形組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222406A (ja) * 1983-06-01 1984-12-14 Teijin Ltd 歯周疾患治療用製剤及びその製造法
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
WO1992005783A1 (fr) * 1990-09-28 1992-04-16 Merck & Co., Inc. Combinaisons d'ibuprofene-antihistamine
JPH08508007A (ja) * 1991-11-19 1996-08-27 センター フォー イノベイティブ テクノロジー ウィルス抑止性抗両受体によるかぜの複合治療法
GB9222849D0 (en) * 1992-10-31 1992-12-16 Smithkline Beecham Plc Novel use of pharmaceutical compositions
JPH08504818A (ja) * 1992-12-21 1996-05-28 ザ、プロクター、エンド、ギャンブル、カンパニー カフェインとs(+)‐イブプロフェン、s(+)‐フルルビプロフェン又はs(+)‐ケトプロフェンを含有した組成物

Also Published As

Publication number Publication date
WO1997004808A1 (fr) 1997-02-13
CO4750820A1 (es) 1999-03-31
AU6599196A (en) 1997-02-26
JPH11510168A (ja) 1999-09-07
CA2227958A1 (fr) 1997-02-13
EP0841947A1 (fr) 1998-05-20
AR003470A1 (es) 1998-08-05

Similar Documents

Publication Publication Date Title
MY120279A (en) Use of a celecoxib composition for fast pain relief
ES2086270T1 (es) Metabolitos de terfenadina y sus isomeros opticamente puros para tratar trastornos alergicos.
DK1137416T3 (da) Anvendelse af langkædede N-alkylderivater af deoxynojirimycin til fremstilling af et lægemiddel til behandling af glycolipidophobnings-sygdomme
ATE109970T1 (de) Cyclosporin-augenmittel.
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
CO5011115A1 (es) Compuestos y metodos quimioquina
GEP20022636B (en) 4-[5-Methyl-3-Phenylisoxazol-4-Yl] Benzenesulfonamide, Its Crystal Structure B, Pharmaceutical Composition Containing The Same, Methods For Treatment Or Prophylaxis Of Disorders Caused By Cyclooxygen-2
PE12098A1 (es) Composiciones y metodos para tratar transtornos respiratorios
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
ATE194987T1 (de) Substituierte dibenzoxazepinverbindungen, pharmazeutische zusammensetzungen und anwendungsmethoden
ATE15596T1 (de) Pharmazeutische mittel.
AR020803A1 (es) Una composicion que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma y el uso de la misma para la manufactura de unmedicamento
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
CO5011084A1 (es) Composiciones y metodos para tratar trastornos respiratorios
ES2116663T3 (es) Compuestos intermediarios para la preparacion de derivados triterpenos antagonistas del receptor de endotelina.
BR0014895A (pt) Formulação lìquida estável, processo para a preparação da mesma, uso da mesma, uso de polietileno glicol e sal de sódio ou potássio de um inibidor h+, k+-atpase, e, método para tratar doenças gastrointestinais
CA2218028A1 (fr) Inhibiteur de l'oedeme cerebral
ES2038716T3 (es) Metodos y composiciones para el tratamiento de la psoriasis.
ES2093246T3 (es) Compuestos de benzazepina terapeuticos.
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient
NO982863L (no) Nye forbindelser med analgetisk effekt
ES2126039T3 (es) Composicion para la profilaxis y tratamiento de la miopia.
NO923198D0 (no) Terapeutiske midler
TR200102087T2 (tr) Yeni morfolinbenzamid tuzları
MX9306005A (es) Combinaciones de ibupropeno-cafeina.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal